Author

E. Y. Faraoni

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

C. J. Wray· 2 shared H. K. Eltzschig· 2 shared K. L. Poulsen· 2 shared L. N. Strickland· 2 shared N. C. Thosani· 2 shared T. Mills· 2 shared V. Y. Mota· 2 shared A. Mohammed· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. J. Wray

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CD73 generated extracellular adenosine promotes resolution of neutrophil-mediated tissue injury and restrains metaplasia in pancreatitis

B. J. O'Brien, E. Y. Faraoni, L. N. Strickland, Z. Ma, V. Y. Mota, S. Y. Mota, X. Chen, T. Mills, H. K. Eltzschig, K. E. DelGiorno, J. M. Bailey-Lundberg

This study shows CD73-generated adenosine reduces neutrophil-driven tissue damage and metaplasia in pancreatitis by promoting inflammation resolution.

bioRxiv · Sep 17, 2022Immunology

Radiofrequency ablation remodels the tumor microenvironment and promotes systemic immunomodulation in pancreatic cancer

E. Y. Faraoni, N. C. Thosani, B. O'Brien, L. N. Strickland, V. Y. Mota, J. K. Chaney, P. Cen, J. Rowe, J. C. Cardenas, K. L. Poulsen, C. J. Wray, J. Bailey-Lundberg

This study shows radiofrequency ablation reduces tumor growth and alters the tumor microenvironment in a mouse model of pancreatic cancer, suggesting potential for combination therapies.

bioRxiv · Jan 7, 2022 · PreprintCancer Biology

Pancreatic cancer ductal cell of origin drives CD73-dependent generation of immunosuppressive adenosine

K. Singh, E. Y. Faraoni, Y. Dai, V. Chandra, E. Vucic, T. Mills, M. Pruski, T. Clark, G. Van Buren, N. C. Thosani, J. S. Bynon, C. J. Wray, D. Bar-Sagi, K. L. Poulsen, L. A. Vornik, , J. Bailey Lundberg

This study identifies CD73 as a key driver of immunosuppression in pancreatic ductal adenocarcinoma, showing its role in adenosine generation and tumor progression.

bioRxiv · Nov 29, 2021 · PreprintCancer Biology